6 research outputs found
Efficient Synthesis of a Series of Novel Octahydroquinazoline-5-ones via a Simple on-Water Urea-Catalyzed Chemoselective Five-Component Reaction
Multicomponent reactions
(MCRs) have become a powerful tool for
drug discovery and development owing to their advantages of fast and
efficient construction of a large library of products with complexity
and diversity. However, conventional MCRs usually proceed in environmentally
unfriendly organic solvents rather than in water, a green solvent
used by nature for biological chemistry. Herein, a simple and efficient
on-water urea-catalyzed chemoselective five-component reaction (5CR)
has been developed for the synthesis of a series of novel octahydroquinazoline-5-ones
(<b>6</b>), the derivatives of quinazolinones possessing diverse
biological activities. The molecular structure of <b>6</b>{<i>1,1,12</i>} has been confirmed by single-crystal X-ray diffraction.
The 5CR can proceed at room temperature under normal atmospheric pressure
in good yields and afford a large library of octahydroquinazoline-5-ones
with various aromatic and aliphatic substituents at N-1, C-2, and
N-3. In addition, a green method has been developed for the synthesis
of enaminones, important intermediates in the 5CR and in synthetic
chemistry
Reduction of Nitric Oxide by Acetylene on Ir Surfaces with Different Morphologies: Comparison with Reduction of NO by CO
Reduction of nitric oxide (NO) by acetylene (C<sub>2</sub>H<sub>2</sub>) has been investigated by temperature-programmed desorption
(TPD) on planar Ir(210) and faceted Ir(210) with tunable sizes of
three-sided nanopyramids exposing (311), (311Ì…), and (110) faces.
Upon adsorption, C<sub>2</sub>H<sub>2</sub> dissociates to form acetylide
(CCH) and H species on the Ir surfaces at low C<sub>2</sub>H<sub>2</sub> precoverage. For adsorption of NO on C<sub>2</sub>H<sub>2</sub>-covered
Ir, both planar and faceted Ir(210) exhibit high reactivity for reduction
of NO with high selectivity to N<sub>2</sub> at low C<sub>2</sub>H<sub>2</sub> precoverage, although the reaction is completely inhibited
at high C<sub>2</sub>H<sub>2</sub> precoverage. Coadsorbed C<sub>2</sub>H<sub>2</sub> significantly influences dissociation of NO. The N-,
H-, and C-containing TPD products are dominated by N<sub>2</sub>,
H<sub>2</sub>, CO, and CO<sub>2</sub> together with small amounts
of H<sub>2</sub>O. For adsorption of NO on C-covered Ir(210) at fractional
C precoverage, formation of CO<sub>2</sub> is promoted while production
of CO is reduced. Reduction of NO by C<sub>2</sub>H<sub>2</sub> is
structure sensitive on faceted Ir(210) versus planar Ir(210), but
no evidence is found for size effects in the reduction of NO by C<sub>2</sub>H<sub>2</sub> on faceted Ir(210) for average facet sizes of
5 nm and 14 nm. The results are compared with reduction of NO by CO
on the same Ir surfaces. As for NO+C<sub>2</sub>H<sub>2</sub>, the
Ir surfaces are very active for reduction of NO by CO with high selectivity
to N<sub>2</sub> and the reaction is structure sensitive, but clear
evidence is found for size effects in the reduction of NO by CO on
the nanometer scale. Furthermore, coadsorbed CO does not affect dissociation
of NO at low CO precoverage whereas coadsorbed CO considerably influences
dissociation of NO at high CO precoverage. The adsorption sites of
CCH+H on Ir are characterized by density functional theory
Novel Terminal Bipheny-Based Diapophytoene Desaturases (CrtN) Inhibitors as Anti-MRSA/VISR/LRSA Agents with Reduced hERG Activity
CrtN has been identified as an attractive
and druggable target
for treating pigmented <i>Staphylococcus aureus</i> infections.
More than 100 new compounds were synthesized, which target the overwhelming
the defects of the CrtN inhibitor <b>1</b>. Analogues <b>23a</b> and <b>23b</b> demonstrated a significant activity
against pigmented <i>S. aureus</i> Newman and 13 MRSA strains
(IC<sub>50</sub> = 0.02–10.5 nM), along with lower hERG inhibition
(IC<sub>50</sub> > 30 μM, ∼10-fold decrease in comparison
with <b>1</b>). Furthermore, <b>23a</b> and <b>23b</b> were confirmed to reduce the staphylococcal load in the kidney and
heart in a mouse model with normal treatment deeper than pretreatment
ones, comparable even with vancomycin and linezolid. Remarkably, <b>23a</b> could strongly block the pigment biosynthesis of these
nine multidrug-resistant MRSA strains, including excellent activity
against LRSA strains and VISA strains in vivo, and all of which demonstrated
that <b>23a</b> has a huge potential against intractable MRSA,
VISA, and LRSA issues as a therapeutic drug
Novel Terminal Bipheny-Based Diapophytoene Desaturases (CrtN) Inhibitors as Anti-MRSA/VISR/LRSA Agents with Reduced hERG Activity
CrtN has been identified as an attractive
and druggable target
for treating pigmented <i>Staphylococcus aureus</i> infections.
More than 100 new compounds were synthesized, which target the overwhelming
the defects of the CrtN inhibitor <b>1</b>. Analogues <b>23a</b> and <b>23b</b> demonstrated a significant activity
against pigmented <i>S. aureus</i> Newman and 13 MRSA strains
(IC<sub>50</sub> = 0.02–10.5 nM), along with lower hERG inhibition
(IC<sub>50</sub> > 30 μM, ∼10-fold decrease in comparison
with <b>1</b>). Furthermore, <b>23a</b> and <b>23b</b> were confirmed to reduce the staphylococcal load in the kidney and
heart in a mouse model with normal treatment deeper than pretreatment
ones, comparable even with vancomycin and linezolid. Remarkably, <b>23a</b> could strongly block the pigment biosynthesis of these
nine multidrug-resistant MRSA strains, including excellent activity
against LRSA strains and VISA strains in vivo, and all of which demonstrated
that <b>23a</b> has a huge potential against intractable MRSA,
VISA, and LRSA issues as a therapeutic drug
Novel Inhibitors of Staphyloxanthin Virulence Factor in Comparison with Linezolid and Vancomycin versus Methicillin-Resistant, Linezolid-Resistant, and Vancomycin-Intermediate <i>Staphylococcus aureus</i> Infections in Vivo
Our
previous work (Wang
et al. J. Med. Chem. 2016, 59, 4831−4848) revealed that effective benzocycloalkane-derived staphyloxanthin
inhibitors against methicillin-resistant <i>Staphylococcus aureus</i> (<i>S. aureus</i>) infections were accompanied by poor
water solubility and high hERG inhibition and dosages (preadministration).
In this study, 92 chroman and coumaran derivatives as novel inhibitors
have been addressed for overcoming deficiencies above. Derivatives <b>69</b> and <b>105</b> displayed excellent pigment inhibitory
activities and low hERG inhibition, along with improvement of solubility
by salt type selection. The broad and significantly potent antibacterial
spectra of <b>69</b> and <b>105</b> were displayed first
with normal administration in the livers and hearts in mice against
pigmented <i>S. aureus</i> Newman, Mu50 (vancomycin-intermediate <i>S. aureus</i>), and NRS271 (linezolid-resistant <i>S. aureus</i>), compared with linezolid and vancomycin. In summary, both <b>69</b> and <b>105</b> have the potential to be developed
as good antibacterial candidates targeting virulence factors
Additional file 1 of GhIMP10D, an inositol monophosphates family gene, enhances ascorbic acid and antioxidant enzyme activities to confer alkaline tolerance in Gossypium hirsutum L.
Additional file 1: Supplementary Table S1. Gene locus ID and their proposed names of all observed species and the gene characteristics in G. hirsutum. Supplementary Table S2. Duplicated gene pairs in 10 combinations (Ga-Ga, Ga-Gb, Ga-Gr, Gb-Gb, Gb-Gr, Gh-Gh, Gh-Ga, Gh-Gb, Gh-Gr and Gr-Gr). Supplementary Table S3. Non-synonymous (Ka) and synonymous (Ks) divergence values for Ga-Ga, Ga-Gb, Ga-Gr, Gb-Gb, Gb-Gr, Gh-Gh, Gh-Ga, Gh-Gb, Gh-Gr and Gr-Gr. Supplementary Table S4. Primer pairs used for this experiment